Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.

The role of inflammation in Alzheimer's disease (AD) and other cognitive disorders is unclear. In a well-defined mono-center population, we measured cytokines and chemokines in paired serum and cerebrospinal fluid (CSF) samples.Consecutive patients with AD (n = 30), stable mild cognitive impair...

Full description

Bibliographic Details
Main Authors:	Per Johansson, Erik G Almqvist, Anders Wallin, Jan-Ove Johansson, Ulf Andreasson, Kaj Blennow, Henrik Zetterberg, Johan Svensson
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5413050?pdf=render

Similar Items

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.
Published: (2013-01-01)

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
by: Annika Öhrfelt, et al.
Published: (2016-07-01)

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid
by: Maria Bjerke, et al.
Published: (2010-01-01)

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
by: Christoffer Rosén, et al.
Published: (2014-07-01)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
by: Henrik Zetterberg, et al.
Published: (2010-01-01)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
by: Ulf Andreasson, et al.
Published: (2016-01-01)

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
by: Bremell Daniel, et al.
Published: (2013-01-01)

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
by: Mikko Hölttä, et al.
Published: (2012-01-01)

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.
by: Mikko Hölttä, et al.
Published: (2013-01-01)

Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
by: Lovisa Tobieson, et al.
Published: (2021-08-01)

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
by: Linn Hermansson, et al.
Published: (2019-01-01)

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.
by: Valter Niemelä, et al.
Published: (2018-01-01)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
by: Karolina Minta, et al.
Published: (2020-10-01)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
by: Rosengren Lars, et al.
Published: (2009-12-01)

Discriminatory analysis of biochip-derived protein patterns in CSF and plasma in neurodegenerative diseases
by: Christoffer eRosen, et al.
Published: (2011-01-01)

<it>BACE1 </it>gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
by: Minthon Lennart, et al.
Published: (2010-09-01)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
by: Rosengren Lars, et al.
Published: (2010-07-01)

Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke
by: Clara Hjalmarsson, et al.
Published: (2014-05-01)

Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke
by: Clara Hjalmarsson, et al.
Published: (2014-01-01)

Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.
by: Sindre Rolstad, et al.
Published: (2015-01-01)

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
by: Marie Eckerström, et al.
Published: (2020-12-01)

Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy.
by: Ulrika Andersson-Hall, et al.
Published: (2021-01-01)

Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study
by: Bromander Sara, et al.
Published: (2012-10-01)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
by: Henrik Zetterberg, et al.
Published: (2021-02-01)

High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS
by: Maria Blomqvist, et al.
Published: (2017-07-01)

The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)

Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
by: Andreas Pikwer, et al.
Published: (2017-09-01)

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system.
by: Niklas Mattsson, et al.
Published: (2012-01-01)

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
by: Claudia Cicognola, et al.
Published: (2021-02-01)

Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases
by: Melinda Rezeli, et al.
Published: (2015-09-01)

Admission Levels of Interleukin 10 and Amyloid β 1–40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain Injury
by: Jussi P. Posti, et al.
Published: (2020-10-01)

Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and <it>PSEN1 </it>A431E-associated familial Alzheimer's disease
by: Galasko Douglas, et al.
Published: (2010-01-01)

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus
by: Karolina Minta, et al.
Published: (2021-05-01)

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
by: Alexander J Lowe, et al.
Published: (2020-01-01)

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
by: Ronald Lautner, et al.
Published: (2017-10-01)

The relationship between cerebrospinal fluid tau markers, hippocampal volume, and delayed primacy performance in cognitively intact elderly individuals
by: Davide Bruno, et al.
Published: (2015-03-01)

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease
by: Niels Andreasen, et al.
Published: (2010-01-01)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
by: Niklas Mattsson, et al.
Published: (2010-01-01)

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
by: Sarah Westwood, et al.
Published: (2017-04-01)

Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies
by: Andreas Bjorefeldt, et al.
Published: (2018-02-01)